Your browser doesn't support javascript.
loading
Individual participant data meta-analysis versus aggregate data meta-analysis: A case study in eczema and food allergy prevention.
Van Vogt, Eleanor; Cro, Suzie; Cornelius, Victoria R; Williams, Hywel C; Askie, Lisa M; Phillips, Rachel; Kelleher, Maeve M; Boyle, Robert J.
Afiliação
  • Van Vogt E; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Cro S; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Cornelius VR; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Williams HC; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
  • Askie LM; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.
  • Phillips R; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Kelleher MM; National Heart and Lung Institute, Section of Inflammation and Repair, Imperial College London, London, UK.
  • Boyle RJ; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
Clin Exp Allergy ; 52(5): 628-645, 2022 05.
Article em En | MEDLINE | ID: mdl-34939249
INTRODUCTION: Meta-analysis traditionally uses aggregate data from published reports. Individual Participant Data (IPD) meta-analysis, which obtains and synthesizes participant-level data, is potentially more informative, but resource-intensive. The impact on the findings of meta-analyses using IPD in comparison with aggregate data has rarely been formally evaluated. METHODS: We conducted a secondary analysis of a Cochrane systematic review of skincare interventions for preventing eczema and food allergy in infants to identify the impact of the analytical choice on the review's findings. We used aggregate data meta-analysis only and contrasted the results against those of the originally published IPD meta-analysis. All meta-analysis used random effects inverse variance models. Certainty of evidence was evaluated using GRADE. RESULTS: The pooled treatment effects for the Cochrane systematic review's co-primary outcomes of eczema and food allergy were similar in IPD meta-analysis (eczema RR 1.03, 95% CI 0.81, 1.31; I2 41%, 7 studies 3075 participants), and aggregate meta-analysis (eczema RR 1.01 95% CI 0.77, 1.33; I2 53%, 7 studies, 3089 participants). In aggregate meta-analysis, the statistical heterogeneity could not be explained but using IPD it was explained by one trial which used a different, bathing intervention. For IPD meta-analysis, risk of bias was assessed as lower and more adverse event data were available compared with aggregate meta-analysis. This resulted in higher certainty of evidence, especially for adverse events. IPD meta-analysis enabled analysis of treatment interactions by age and hereditary eczema risk; and analysis of the effect of treatment adherence using pooled complier-adjusted-causal-effect analysis, none of which was possible in aggregate meta-analysis. CONCLUSIONS: For this systematic review, IPD did not significantly change primary outcome risk ratios compared with aggregate data meta-analysis. However, certainty of evidence, safety outcomes, subgroup and adherence analyses were significantly different using IPD. This demonstrates benefits of adopting an IPD approach to meta-analysis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eczema / Hipersensibilidade Alimentar Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans / Infant Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eczema / Hipersensibilidade Alimentar Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans / Infant Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article